Videos

Rebecca Thurston, PhD, sits down to discuss the latest news from the North American Menopause Society Annual Meeting.

Katie Huffling, DNP, RN, CNM, FAAN, shares how you can help educate your pregnant patients to become more educated consumers.

Anne Moore, DNP, WHNP/ANP-BC, FAANP, sat down to talk about a new drug combination for COCs.

Amy Levi, CNM, WHNP-BC, FACNM, FAAN, Albers Endowed Professor of Midwifery at the University of New Mexico College of Nursing, sits down to discuss her presentation at the NPWH 25th Annual Premier Women's Healthcare Conference on medications for early pregnancy loss.

Lois McGuire, MSN, APRN, WHNP-BC, NCMP, shared her expertise in perimenopausal contraception during the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Premier Women’s Health Conference, held in Houston, Texas from September 28 to October 2, 2022.

Genevieve Hoffman, DNP, WHNP-BC, sat down to share key highlights from her presentation on menopausal care at the NPWH 25th Annual Premier Women's Healthcare Conference.

Nkechi Azie, MD, MBA, FIDSA, vice president of clinical development and medical affairs at SCYNEXIS, discusses the potential FDA approval of ibrexafungerp (Brexafemme; SCYNEXIS) for the prevention of recurrent vulvovaginal candidiasis.

Marina Sirota, PhD, associate professor of pediatrics at the University of California, San Francisco, spoke about the new March of Dimes Prematurity Research Center at UCSF and the impact they hope their research will have on the future of preterm birth.

Experts discuss the trajectory of CMV awareness and vaccine development efforts.

Allison August, MD, Kathleen Muldoon, PhD, Stanley Plotkin, MD, and Patricia Purcell, MD, MPH, reveal tips regarding the most important points to emphasize when talking to patients about CMV.

Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).

John Martin, MD, chief medical officer at Butterfly Network, discusses a recent study published in NEJM Evidence, which investigated Butterfly iQ vs a commercial ultrasound machine to detect gestational age.

Thought leaders discuss the low rates of screening for CMV and what healthcare providers can do to boost prevention efforts.

Allison August, MD, Kathleen Muldoon, PhD, Stanley Plotkin, MD, and Patricia Purcell, MD, MPH, explore key strategies and takeaways that healthcare providers can use to discuss transmission of CMV with their patients.

Allison August, MD, Kathleen Muldoon, PhD, Stanley Plotkin, MD, and Patricia Purcell, MD, MPH, share recommendations for messaging that healthcare providers should be sharing regarding CMV.

Allison August, MD, Kathleen Muldoon, PhD, Stanley Plotkin, MD, and Patricia Purcell, MD, MPH, share recommendations for messaging that healthcare providers should be sharing regarding CMV.

Bethany Corbin, Esq., sits down with Contemporary OB/GYN® to discuss the recent Supreme Court ruling overturning Roe v Wade and striking down almost 50 years of abortion precedent.

Drs Emily K. Hill, Sangini S. Sheth, and Mark H. Stoler share practice pearls for HPV and cervical cancer screening and express their hope for emerging testing options.

Experts in obstetric and gynecologic management provide insight on the role of HPV genotypes in cervical cancer risk.

Mark H. Stoler, MD, FASCP, provides insight on the role of dual testing in the management of HPV positive women.

Drs Sangini S. Sheth and Mark H. Stoler share their thoughts on the adoption of primary HPV screening and how they foresee changes to cervical cancer screening as more individuals get vaccinated.

Thomas C. Wright Jr., MD; Emily K Hill, MD; and Sangini S. Sheth, MD, MPH, FACOG, comment on the impact COVID-19 had on HPV and cervical cancer screening in their respective practices.

Drs Emily K. Hill, Sangini S. Sheth, and Mark H. Stoler, comment on the implementation considerations surrounding HPV and cervical cancer screening.

“We actually found that treatment with percutaneous tibial nerve stimulation was…a safe and very effective way of improving sexual function,” says Varun R. Talanki, MD.

Emily K. Hill, MD, reviews the current US HPV and cervical cancer screening guidelines from the American Cancer Society, American College of Obstetricians and Gynecologists, and the American Society for Colposcopy and Cervical Pathology and discusses the differences within.

Experts in obstetric and gynecologic management examine conventional cervical cancer screening strategies and consider their specificity and sensitivity targets.

Bassem Maximos, MD, MPH, FACOG, discusses 2 recent studies investigating nonhormomal contraceptive gel Phexxi (Evofem Biosciences) for the potential treatment of UTIs and improvement in sexual satisfaction.

Tracy MacNeal, president and CEO of Materna Medical, sits down to discuss the company's recently FDA-cleared Milli Vaginal Dilator for vaginismus and associated dyspareunia, as well as a potential new use for the device currently being studied.

Drs Mark H. Stoler, Emily K. Hill, Sangini S. Sheth, and Thomas C. Wright comment on the general awareness around HPV and cervical cancer in patients as well as the importance of increasing routine cervical cancer screening approaching those conversations with patients.

Emily K. Hill, MD; Sangini S. Sheth, MD, MPH, FACOG, and Mark. H. Stoler, MD, FASCP, review the rationale of screening for HPV and vaccinating patients to prevent progression to cervical cancer.